Arvee Laboratories (India) share news, announcements and annual reports
NSE: ARVEEChemicals & PetrochemicalsSmall Cap
Arvee Laboratories (India) Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2018 · Issue price ₹61
Last close ₹206.71up ₹9.84 (5.00%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹196.87.
30 Oct: open ₹205.00, high ₹206.71, low ₹199.00
52-week range of traded prices to 30 Oct 2026
₹129.11Low, 30 Mar 2026₹290.78High, 19 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹228 Cr2,476th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 56.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.74
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,97864.8% delivered
Arvee Laboratories (India) share news and announcements
259 announcements, routine notices left out, newest first. Page 2 of 6.
May 2024
17 May · Results
17 May · Board meeting
Apr 2024
8 Apr · Legal
Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.1 Apr · Updates
Mar 2024
26 Mar · Management
Feb 2024
13 Feb · Results
5 Feb · Board meeting
Meeting on 13 Feb 2024: “ARVEE LABORATORIES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Qua”
Jan 2024
27 Jan · Board meeting
Dec 2023
11 Dec · Legal
The exchange asked on 11 Dec 2023
Nov 2023
7 Nov · Board meeting
7 Nov · Board meeting
7 Nov · Results
Oct 2023
Sep 2023
22 Sep · Meeting
2 Sep · Updates
Aug 2023
25 Aug · Disclosure of Annual financial information (if submitted as part of Annual Report)
11 Aug · Results
Jul 2023
Jun 2023
21 Jun · Legal
Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
May 2023
21 May · Updates
5 May · Board meeting
5 May · Results
Apr 2023
28 Apr · Corrigendum
18 Apr · Legal
The exchange asked on 17 Apr 2023
Feb 2023
2 Feb · Results
Jan 2023
Dec 2022
8 Dec · Legal
The exchange asked on 7 Dec 2022
Nov 2022
15 Nov · Related Party Transaction
Sep 2022
Aug 2022
23 Aug · General updates
4 Aug · General updates